Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Epithelial cells which line mucosal surfaces are the first line of defense against bacterial invasion and infection. Recent studies have also indicated that epithelial cells contribute significantly to the orchestration of ongoing inflammatory processes. Here, we demonstrate that human epithelial cells express bactericidal/permeability-increasing protein (BPI), an antibacterial and endotoxin-neutralizing molecule previously associated with neutrophils. Moreover, we demonstrate that such BPI expression is transcriptionally regulated by analogs of endogenously occurring anti-inflammatory eicosanoids (aspirin-triggered lipoxins, ATLa). Initial studies to verify microarray analysis revealed that epithelial cells of wide origin (oral, pulmonary, and gastrointestinal mucosa) express BPI and each is similarly regulated by aspirin-triggered lipoxins. Studies aimed at localization of BPI revealed that such expression occurs on the cell surface of cultured epithelial cell lines and dominantly localizes to epithelia in human mucosal tissue. Functional studies employing a BPI-neutralizing anti-serum revealed that surface BPI blocks endotoxin-mediated signaling in epithelia and kills Salmonella typhimurium . These studies identify a previously unappreciated “molecular shield” for protection of mucosal surfaces against Gram-negative bacteria and their endotoxin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [102]
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [102]
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [102]
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [102]
Citations
Cites
Expression monitoring by hybridization to high-density oligonucleotide arrays
Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Norton, H., et al. (1996) · Nature Biotechnology · doi:10.1038/nbt1296-1675 · Cited by 2,840
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Identification of an inducible endothelial-leukocyte adhesion molecule.
Bevilacqua, M. P., Pober, J. S., Mendrick, D. L., Cotran, R. S., & Gimbrone, M. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9238 · Cited by 1,609
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationCario, E., & Podolsky, D. K. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7010-7017.2000 · Cited by 1,246
Dickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P., & Rheinwald, J. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1436-1447.2000 · Cited by 1,104
Pugin, J., Schürer-Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J., & Tobias, P. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2744 · Cited by 831
Weiss, J., Elsbach, P., Olsson, I., & Odeberg, H. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40872-6 · Cited by 451
McCormick, B. A., Colgan, S. P., Delp-Archer, C., Miller, S. I., & Madara, J. L. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.4.895 · Cited by 447
Self-citationToll receptors in innate immunity
Imler, J.-L., & Hoffmann, J. A. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02004-9 · Cited by 432
Research works printed but not linked: 4
- T Ganz, J Weiss Semin Hematol 34, 343–354 (1997).
- R S Cotran, T Mayadas-Norton Pathol Biol 46, 164–170 (1998).
- R B Sartor Inflammatory Bowel Disease, eds J B Kirsner, R J Shorter (Williams & Wilkins, Baltimore), pp. 96–124 (1995).
- M M Haapamaki, J O Haggblom, J M Gronroos, E Pekkala, K Alanen, T J Nevalainen Hepato-Gastroenterology 46, 2273–2277 (1999).
Cited by
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
“2 ), and stimulate the antimicrobial activities of mucosal epithelial cell”
BackgroundSelf-citationTransition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationSpecialized pro-resolving mediators: endogenous regulators of infection and inflammation
Basil, M. C., & Levy, B. D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.4 · Cited by 791
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
“To date, BPI has been isolated from rabbit PMN cells, human epithelial cells and PMN cells (Canny et al., 2002).”
BackgroundNeutrophil granules: a library of innate immunity proteins
Borregaard, N., Sørensen, O. E., & Theilgaard-Mönch, K. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.06.002 · Cited by 739
Homeostasis of the gut barrier and potential biomarkers
Wells, J. M., Brummer, R. J., Derrien, M., MacDonald, T. T., Troost, F., Cani, P. D., Theodorou, V., Dekker, J., Méheust, A., de Vos, W. M., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00048.2015 · Cited by 620
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
Zhang, S., Ermann, J., Succi, M. D., Zhou, A., Hamilton, M. J., Cao, B., Korzenik, J. R., Glickman, J. N., Vemula, P. K., Glimcher, L. H., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5657 · Cited by 467
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Self-citationSerhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.002 · Cited by 454
Self-citationRvE1 protects from local inflammation and osteoclastmediated bone destruction in periodontitis
Hasturk, H., Kantarci, A., Ohira, T., Arita, M., Ebrahimi, N., Chiang, N., Petasis, N. A., Levy, B. D., Serhan, C. N., & Van Dyke, T. E. (2006) · The FASEB Journal · doi:10.1096/fj.05-4724fje · Cited by 435
Self-citationNovel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
Serhan, C. N. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100322 · Cited by 421
“mucosal epithelial cells to produce antimicrobial peptides.(43,92) Because LX and Rvs control inflammation by stimulating resolution without immune suppression, limiting local inflammation by reducing PMN, and enhancing the M cleanup, a new chemical mediator function for SPM was introduced to describe their temporal b…”
BackgroundSelf-citationZhao, S., Li, Y., Liu, Q., Li, S., Cheng, Y., Cheng, C., Sun, Z., Du, Y., Butch, C. J., & Wei, H. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004692 · Cited by 349
Gronert, K., Maheshwari, N., Khan, N., Hassan, I. R., Dunn, M., & Laniado Schwartzman, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410638200 · Cited by 310
Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
N. Serhan, C., Krishnamoorthy, S., Recchiuti, A., & Chiang, N. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611109060629 · Cited by 276
Self-citationZhang, S., Langer, R., & Traverso, G. (2017) · Nano Today · doi:10.1016/j.nantod.2017.08.006 · Cited by 250
Intestinal antimicrobial peptides during homeostasis, infection, and disease
Muniz, L. R., Knosp, C., & Yeretssian, G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00310 · Cited by 252
“In order to control inflammation in the GI tract and eliminate bacteria, BPI has the ability to bind to LPS and neutralize its activity, whereas CCL20 is a potent chemotactic agent for T cell and DC subsets (Elsbach et al., 1994; Izadpanah et al., 2001; Canny et al., 2002; Yang et al., 2003).”
BackgroundBafica, A., Scanga, C. A., Serhan, C., Machado, F., White, S., Sher, A., & Aliberti, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23949 · Cited by 253
“Interestingly, stimulation of mucosal epithelial cells with lipoxin analogs induced the expression of a bactericidal/permeability-increasing protein, which exhibits antimicrobial activities and enables epithelial cells to engage in active microbial host defense (25, 26).”
Self-citationImmunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection
de Repentigny, L., Lewandowski, D., & Jolicoeur, P. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.729-759.2004 · Cited by 228
“T cells, keratinocytes, and PMNs.”
BackgroundInfluentialRychlik, I., & Barrow, P. A. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2005.03.005 · Cited by 215
“CAMP are found on a number of mucosal surfaces including the epithelium of the respiratory and intestinal tracts [192] and are likely to affect colonisation and infection [193].”
Müller, C. A., Autenrieth, I. B., & Peschel, A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5034-2 · Cited by 207
Kunisawa, J., & Kiyono, H. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5035-1 · Cited by 203
Levy, O. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.2.159 · Cited by 188
Self-citationAntimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes
Levy, O. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0604320 · Cited by 191
“BPI is expressed by human mucosal epithelia in vitro and in vivo [173], and epithelial cells throughout the upper airways express a rapidly growing family of BPI-like proteins (based on homology to a palate lung and nasal clone) [174].”
BackgroundSelf-citationBacteria in the Intestine, Helpful Residents or Enemies from Within?
Canny, G. O., & McCormick, B. A. (2008) · Infection and Immunity · doi:10.1128/iai.00187-08 · Cited by 186
“faces against gram-negative bacteria and their endotoxins (12, 13).”
BackgroundSelf-citationAntimicrobial peptides of the oral cavity
Gorr, S. (2009) · Periodontology 2000 · doi:10.1111/j.1600-0757.2009.00310.x · Cited by 186
Novel ? ? 3-derived local mediators in anti-inflammation and resolution
NSERHAN, C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.09.002 · Cited by 181
The Role of Inflammation in Colon Cancer
Janakiram, N. B., & Rao, C. V. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-0348-0837-8_2 · Cited by 151
“…was shown to inhibit neutrophil chemotaxis, adherence, transmigration, and activation during resolution of inflammation and suppression of IL-8 production by epithelia and leukocytes and to cause clearing of neutrophils by up-regulation of monocyte ingestion (Serhan 1997, 2002; Canny et al. 2002).”
BackgroundSerhan, C. N. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0695-8 · Cited by 175
“2000b) LX and ATL stimulate host antimicrobial activity (Canny et al. 2002) Endothelium Granuloma Reduce angiogenic phenotype (Fierro et al.”
BackgroundSelf-citationBoosting Inflammation Resolution in Atherosclerosis
Fredman, G., & Tabas, I. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.01.018 · Cited by 174
SERHAN, C. N. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03396.x · Cited by 166
Self-citationDefensins and other antimicrobial peptides in inflammatory bowel disease
Wehkamp, J., Schmid, M., & Stange, E. F. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328136c580 · Cited by 165
Zhu, L., Yu, T., Wang, W., Xu, T., Geng, W., Li, N., & Zan, X. (2024) · Advanced Materials · doi:10.1002/adma.202308728 · Cited by 161
The Vibrio cholerae ToxR-Regulated Porin OmpU Confers Resistance to Antimicrobial Peptides
Mathur, J., & Waldor, M. K. (2004) · Infection and Immunity · doi:10.1128/iai.72.6.3577-3583.2004 · Cited by 166
“It was also recently reported to be expressed as a surface protein on human gastrointestinal tract epithelial cells (6).”
BackgroundInfluentialExpression and regulation of antimicrobial peptides in the gastrointestinal tract
Cunliffe, R. N., & Mahida, Y. R. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0503249 · Cited by 161
“Bactericidal/permeabilityincreasing protein, an antibacterial and endotoxin-neutralizing protein known to be produced by neutrophils, has recently been shown to be expressed by colonic epithelial cells, predominantly in the crypt and surface epithelial cells, with reduced expression in cells in the intermediate zone […”
BackgroundRole of Innate Immunity in Neonatal Infection
Cuenca, A., Wynn, J., Moldawer, L., & Levy, O. (2013) · American Journal of Perinatology · doi:10.1055/s-0032-1333412 · Cited by 160
Self-citationIBD Candidate Genes and Intestinal Barrier Regulation
McCole, D. F. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000090 · Cited by 161
“bactericidal lectins such as RegIII proteins that help to maintain a relative bacterial sterility on the epithelial surface.(2,20,21) Expression of antimicrobial peptides is mostly reduced in IBD.”
BackgroundKeep calm: the intestinal barrier at the interface of peace and war
Thoo, L., Noti, M., & Krebs, P. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2086-z · Cited by 159
Microglia and Monocyte-Derived Macrophages in Stroke
Kim, E., & Cho, S. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0463-1 · Cited by 173
Dorschner, R. A., Lin, K. H., Murakami, M., & Gallo, R. L. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000057205.64451.b7 · Cited by 151
“production of antimicrobial peptides and proteins (8, 9).”
BackgroundLipoxins: endogenous regulators of inflammation
McMahon, B., & Godson, C. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00224.2003 · Cited by 148
“Human GI epithelial cells treated with ATL stimulate production of a bactericidal/permeabilityincreasing protein (BPI), a protective protein that inhibits endotoxin signaling (15).”
BackgroundNeutrophil Development, Migration, and Function in Teleost Fish
Havixbeck, J. J., & Barreda, D. R. (2015) · Biology · doi:10.3390/biology4040715 · Cited by 163
Wehkamp, J., Koslowski, M. J., Wang, G., & Stange, E. F. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.48 · Cited by 150
Inflammatory bowel disease: an impaired barrier disease
Jäger, S., Stange, E. F., & Wehkamp, J. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-1030-9 · Cited by 158
“Its spectrum covers Gram-negative bacteria [29, 30].”
ROS-responsive hyaluronic acid hydrogel for targeted delivery of probiotics to relieve colitis
Huang, L., Wang, J., Kong, L., Wang, X., Li, Q., Zhang, L., Shi, J., Duan, J., & Mu, H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.247 · Cited by 137
Lipoxin A4 Regulates Bronchial Epithelial Cell Responses to Acid Injury
Bonnans, C., Fukunaga, K., Levy, M. A., & Levy, B. D. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051056 · Cited by 142
“More than a mechanical interface, epithelial cells also have pivotal regulatory roles in inflammation(1) and host defense.(2) Aspiration of gastric acid can directly injure the upper respiratory tract epithelium, leading to disruption of the epithelial barrier, cell shedding, and acute inflammation.”
BackgroundLi, M., Liu, J., Shi, L., Zhou, C., Zou, M., Fu, D., Yuan, Y., Yao, C., Zhang, L., Qin, S., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.01.015 · Cited by 137
The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease
Schultz, H., & Weiss, J. P. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.07.005 · Cited by 125
Serhan, C. N. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080231 · Cited by 132
Self-citationOuyang, Y., Zhao, J., & Wang, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.12.032 · Cited by 134
Resolvins: Natural agonists for resolution of pulmonary inflammation
Uddin, M., & Levy, B. D. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.09.002 · Cited by 126
“Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP. Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.”
BackgroundInfluentialInflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease
Kotla, N. G., Singh, R., Baby, B. V., Rasala, S., Rasool, J., Hynes, S. O., Martin, D., Egan, L. J., Vemula, P. K., Jala, V. R., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121364 · Cited by 111
Innate immune defenses in the intestinal tract
Dann, S. M., & Eckmann, L. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32803cadf4 · Cited by 103
Serhan, C. N., & Chiang, N. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00117-0 · Cited by 120
“A BPIneutralizing antiserum revealed that surface BPI blocks endotoxin-mediated signaling in epithelia and kills Salmonella typhimurium [67].”
BackgroundSelf-citationHierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine
Li, W., Li, Y., Liu, Z., Kerdsakundee, N., Zhang, M., Zhang, F., Liu, X., Bauleth‐Ramos, T., Lian, W., Mäkilä, E. M., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.024 · Cited by 110
Mathur, J., Davis, B. M., & Waldor, M. K. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05544.x · Cited by 106
“BPI (for ‘bactericidal/permeabilityincreasing’) is a cationic protein expressed on the surface of human intestinal epithelial cells (Canny et al., 2002; Levy et al., 2003) as well as in neutrophil granules (Weiss et al., 1978).”
BackgroundThe role of pro‐resolution lipid mediators in infectious disease
Russell, C. D., & Schwarze, J. (2014) · Immunology · doi:10.1111/imm.12206 · Cited by 102
“27 found that lipoxin up-regulated the expression of bactericidal/perme-ability-increasing protein (BPI).”
BackgroundLovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4
Planagumà, A., Pfeffer, M. A., Rubin, G., Croze, R. H., Uddin, M., Serhan, C. N., & Levy, B. D. (2010) · Mucosal Immunology · doi:10.1038/mi.2009.141 · Cited by 107
Self-citationLBP/BPI proteins and their relatives: conservation over evolution and roles in mutualism
Krasity, B. C., Troll, J. V., Weiss, J. P., & McFall‐Ngai, M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391039 · Cited by 100
Of Microbes and Meals: The Health Consequences of Dietary Endotoxemia
Kelly, C. J., Colgan, S. P., & Frank, D. N. (2012) · Nutrition in Clinical Practice · doi:10.1177/0884533611434934 · Cited by 99
Self-citationSerhan, C. N. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.012 · Cited by 108
Self-citationEpithelia: Not just physical barriers
Ganz, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072073199 · Cited by 101
Lipoxins: Potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease
Kieran, N. E., MADERNA, P., & Godson, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00487.x · Cited by 100
Norling, L. V., & Serhan, C. N. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02235.x · Cited by 115
Self-citationAbergel, C., Monchois, V., Byrne, D., Chenivesse, S., Lembo, F., Lazzaroni, J. C., & Claverie, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611019104 · Cited by 94
Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer
Janakiram, N. B., Mohammed, A., & Rao, C. V. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9311-2 · Cited by 105
Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis
Hou, L., Gong, F., Liu, B., Yang, X., Chen, L., Li, G., Gong, Y., Liang, C., Yang, N., Shen, X., et al. (2022) · Theranostics · doi:10.7150/thno.70668 · Cited by 91
“Many positively charged proteins and excessive ROS were frequently observed in the inflamed colon lesions.[14] Negatively charged nanoplatforms targeting positively charged proteins and scavenging excess ROS represent an extremely effective treatment for alleviating inflammation.”
BackgroundEndogenous lipid mediators in the resolution of airway inflammation
Haworth, O., & Levy, B. D. (2007) · European Respiratory Journal · doi:10.1183/09031936.00005807 · Cited by 88
Lipid mediators in immune dysfunction after severe inflammation
Fullerton, J. N., O’Brien, A. J., & Gilroy, D. W. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.008 · Cited by 89
Phylogenetic and evolutionary analysis of the PLUNC gene family
Bingle, C. D., LeClair, E. E., Havard, S., Bingle, L., Gillingham, P., & Craven, C. J. (2004) · Protein Science · doi:10.1110/ps.03332704 · Cited by 89
“are not significantly expressed, although certain cell lines from these tissues have been shown to express both proteins (Dentener et al. 2000; Canny et al. 2002).”
BackgroundZaborina, O., Kohler, J. E., Wang, Y., Bethel, C., Shevchenko, O., Wu, L., Turner, J. R., & Alverdy, J. C. (2006) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-5-14 · Cited by 83
Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites
Canny, G., & Levy, O. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.012 · Cited by 82
Self-citationCrouch, M. V., Becker, L. A., Bang, I. S., Tanabe, H., Ouellette, A. J., & Fang, F. C. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04578.x · Cited by 80
Guo, X., Rosa, A. J. M., Chen, D., & Wang, X. (2007) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2007.09.016 · Cited by 80
“BPI is recognized as a ‘‘molecular shield’’ for mucosal surface protection (Canny et al., 2002).”
Innate and adaptive mechanisms to control of pathological intestinal inflammation
Kelsall, B. (2008) · The Journal of Pathology · doi:10.1002/path.2286 · Cited by 77
“BPI was recently shown to be constitutively expressed by human and mouse epithelial cells, most highly in the proximal small intestine [81,82], and its over-expression by epithelial cell lines resulted in bacterial killing [81].”
BackgroundLipid Mediators as Agonists for the Resolution of Acute Lung Inflammation and Injury
Bonnans, C., & Levy, B. D. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0269tr · Cited by 85
“LXs enhance mucosal host defense by controlling pathogen-induced inflammatory responses (16, 19) and inducing bactericidal permeability–inducing protein expression in gastrointestinal epithelia (20).”
Background15-epi-Lipoxin A4, Resolvin D2, and Resolvin D3 Induce NF-κB Regulators in Bacterial Pneumonia
Sham, H. P., Walker, K. H., Abdulnour, R.-E. E., Krishnamoorthy, N., Douda, D. N., Norris, P. C., Barkas, I., Benito-Figueroa, S., Colby, J. K., Serhan, C. N., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1602090 · Cited by 82
“Because 15-epiLXA4 is known to induce antimicrobial peptides in intestinal epithelial cells (9), 15-epi-LXA4’s impact on antimicrobial peptide expression by airway epithelial cells was examined.”
BackgroundSelf-citationFecundity compensation and tolerance to a sterilizing pathogen in D aphnia
Vale, P. F., & Little, T. J. (2012) · Journal of Evolutionary Biology · doi:10.1111/j.1420-9101.2012.02579.x · Cited by 89
“There is a great diversity of mechanisms that mediate anti-infection resistance, from nonspecific physical and chemical barriers (Canny et al., 2002; Corteel et al., 2009) to other more specific mechanisms of entry based on effector–receptor molecule recognition (e.g. Bergelson et al., 2001; Frank,…”
BackgroundKesharwani, S. S., Ahmad, R., Bakkari, M. A., Rajput, M., Dachineni, R., Valiveti, C. K., Kapur, S., Bhat, G. J., Singh, A. B., & Tummala, H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.004 · Cited by 76
Commensal-Epithelial Signaling Mediated via Formyl Peptide Receptors
Wentworth, C. C., Jones, R. M., Kwon, Y. M., Nusrat, A., & Neish, A. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100529 · Cited by 76
Britto, C. J., & Cohn, L. E. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0297rt · Cited by 70
“family, such as BPI, known to be produced by neutrophils (6, 32, 49, 50).”
BackgroundSchultz, H., Hume, J. R., Zhang, D. S., Gioannini, T. L., & Weiss, J. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2477 · Cited by 70
Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins
Petasis, N. A., Akritopoulou‐Zanze, I., Fokin, V. V., Bernasconi, G., Keledjian, R., Yang, R., Uddin, J., Venkata, K. C. N., & Serhan, C. N. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.020 · Cited by 76
“This synthetic compound (50) was also used for the examination of the possible role of LX/ATL in the pathogenesis and potential systemic or topical therapy for a number of inflammatory disorders, including skin inflammation [148–150], mucosal infection [151], colitis [152], vascular injury [135,137,140,153], asthma [1…”
BackgroundMethodSelf-citationPetasis, N. A., Keledjian, R., Sun, Y., Venkata, K. C. N., Tjonahen, E., Yang, R., & Serhan, C. N. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.013 · Cited by 67
Self-citationCerebellar Brain Abscess Associated with Tongue Piercing
Martinello, R. A., & Cooney, E. L. (2003) · Clinical Infectious Diseases · doi:10.1086/345755 · Cited by 66
Warner, D. R., Warner, J. B., Hardesty, J., Song, Y., King, T. N., Kang, J. X., Chen, C., Xie, S., Yuan, F., Prodhan, M. A. I., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.ra119000200 · Cited by 71
“Bpi is transcriptionally upregulated by lipoxins (63) and exerts a potent (nanomolar) and selective bioactivity against gram-negative bacterial species.”
BackgroundLipoxins in the eye and their role in wound healing
Gronert, K. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.009 · Cited by 69
Antimicrobial Proteins and Peptides in Early Life: Ontogeny and Translational Opportunities
Battersby, A., Khara, J. S., Wright, V., Levy, O., & Kampmann, B. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00309 · Cited by 69
“responses(10,30), modulating adaptive cellular immune responses(13,31) mediating 80 immune cell ontogeny in the lung and gut and acting as chemoattractants for other immune 81”
BackgroundSelf-citationDalli, J., Kraft, B. D., Colas, R. A., Shinohara, M., Fredenburgh, L. E., HESS, D. R., Chiang, N., Welty‐Wolf, K. E., Choi, A. M. K., Piantadosi, C. A., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0299oc · Cited by 64
“SPMs also regulate the production of antimicrobial peptides by human mucosal epithelial cells (20).”
BackgroundSelf-citationHo, T. D., & Waldor, M. K. (2007) · Infection and Immunity · doi:10.1128/iai.01342-06 · Cited by 62
“BPI is a 55- to 60-kDa protein that is found in the blood and on surfaces of epithelial cells throughout the gastrointestinal tract (2).”
BackgroundMontgomery, M. T., Sajuthi, S. P., Cho, S., Everman, J. L., Rios, C. L., Goldfarbmuren, K. C., Jackson, N. D., Saef, B. A., Cromie, M. M., Eng, C. S., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0454oc · Cited by 68
“Interestingly, this analysis resulted in a mucus secretory coexpression module containing MUC5AC as well as two of the BPI-fold containing genes (BPIFA1 and BPIFB1), which encode antimicrobial defense proteins produced by secretory epithelial cells (23).”
BackgroundZhao, N., Yang, F., Zhao, C., Lv, S., Wang, J., Liu, J., & Wang, S. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101618 · Cited by 60
Cui, Y., Yang, D., Li, Q., Peng, Z., Zhong, Z., Song, Y., Han, Q., & Yang, Y. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c03627 · Cited by 59
Walley, K. R., Francis, G. A., Opal, S. M., Stein, E. A., Russell, J. A., & Boyd, J. H. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0876ci · Cited by 67
Hsiao, H.-M., Thatcher, T. H., Levy, E. P., Fulton, R. A., Owens, K. M., Phipps, R. P., & Sime, P. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400313 · Cited by 60
Cloning and analyses of a BPI/LBP cDNA of the Atlantic cod (Gadus morhua L.)
Stenvik, J., Solstad, T., Strand, C., Leiros, I., & Jørgensen, T. Ø. (2003) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2003.09.002 · Cited by 57
Duvall, M. G., Brüggemann, T. R., & Levy, B. D. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.003 · Cited by 59
Antimicrobial Aspects of Inflammatory Resolution in the Mucosa: A Role for Proresolving Mediators
Campbell, E. L., Serhan, C. N., & Colgan, S. P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100150 · Cited by 58
“Additional studies in human and murine tissue ex vivo revealed that BPI is diffusely expressed along the crypt-villous axis (14, 68), and that epithelial BPI protein levels decrease along the length of the intestine (69).”
BackgroundInfluentialSelf-citationRelease of Anti‐HIV Mediators after Administration of Leukotriene B4to Humans
Flamand, L., Borgeat, P., Lalonde, R., & Gosselin, J. (2004) · The Journal of Infectious Diseases · doi:10.1086/386374 · Cited by 57
“[47] provided evidence that a lipoxin A4 (LXA4) analogue modulates the expression of the bactericidal/permeability-increasing protein in epithelial cells, which suggests a potential protective role for LXA4 in mucosal immunity.”
BackgroundResolution of Inflammation in Asthma
Levy, B. D., Vachier, I., & Serhan, C. N. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2012.06.006 · Cited by 63
“To this end, proresolving mediators decrease allergic edema,(27) recruit monocytes in a nonphlogistic fashion,(28) increase phagocytosis and efferocytosis by macrophages,(29) increase chemokine scavenging by apoptotic neutrophils (via C-C chemokine receptor type 5 [CCR5] expression),(30) enhance luminal clearance of t…”
Self-citation
Metadata
- Authors
- Canny, G., Levy, O., Furuta, G. T., Narravula-Alipati, S., Sisson, R. B., Serhan, C. N., & Colgan, S. P.
- Affiliations
- University College Dublin (IE)
- Department of Veterinary Physiology, University College of Dublin, Dublin 4, Ireland; and Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Boston, MA 02115; and Divisions of Infectious Diseases and Pediatric Gastroenterology, Children's Hospital and Harvard Medical School, Boston, MA 02115
- Corresponding author
- Colgan, Sean P.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-03-12
- Volume
- 99
- Issue
- 6
- Pages
- 3902-3907
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122621
- OpenAlex
- W2051793746
- Cited by
- 295
- References
- 49
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 6 · 2023: 5 · 2022: 15 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 11 · 2016: 9 · 2015: 16 · 2014: 12 · 2013: 11 · 2012: 11
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (4r37gm038765-19)
- National Institute of General Medical Sciences (GM 38765, R01GM038765, R37-GM038765)
- National Institute of Allergy and Infectious Diseases (K08AI050583)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050189, R37DK050189, R29DK050189, DK-50189)
- National Institute of Dental and Craniofacial Research (DE13499, P01DE013499)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- bactericidal/permeability-increasing protein, BPI, aspirin-triggered lipoxins, eicosanoids, endotoxin neutralization, lipopolysaccharide signaling, Salmonella typhimurium, antibacterial defense, oral mucosa, gastrointestinal mucosa, transcriptional regulation, Gram-negative bacteria
- MeSH terms
- Anti-Inflammatory Agents, Anti-Bacterial Agents, Blood Proteins, Cell Line, Cell Membrane, Epithelial Cells, Gene Expression Regulation, Humans, Inflammation, Lipids, Lipopolysaccharides, Membrane Proteins, Mucous Membrane, Salmonella typhimurium, Caco-2 Cells, Protein Transport, Antimicrobial Cationic Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.